Wellgistics Health updates warrant exhibit

Wellgistics Health, Inc. filed an amendment to a prior current report to update a single exhibit.

Accepted by SEC EDGAR 06/03/2026 - 04:15 PM EDT

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K/A

Rhea-AI Filing Summary

Wellgistics Health, Inc. filed an amendment to a prior current report to update a single exhibit. Amendment No. 2 replaces and refiles Exhibit 4.3, described as the Form of Placement Agent Warrant that was previously included with Amendment No. 1. The company states that no other disclosures or exhibits from the original report or Amendment No. 1 are modified, and the amendment does not reflect any subsequent events.

8-K Event Classification

Item 9.01 — Financial Statements and Exhibits

1 item

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Terms

Placement Agent Warrant, Emerging growth company, Inline XBRL

3 terms

Placement Agent Warrant financial

"The purpose of this Amendment No. 2 is to replace and refile Exhibit 4.3 included with Amendment No. 1. 4.3 | | Form of Placement Agent Warrant."

Emerging growth company regulatory

"Emerging growth company Explanatory Note This Amendment No. 2"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Inline XBRL technical

"104 | | Cover Page Interactive Data File (embedded within the Inline XBRL document)."

Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the purpose of Wellgistics Health (WGRX) Amendment No. 2?

The amendment’s sole purpose is to replace and refile Exhibit 4.3, the Form of Placement Agent Warrant. It clarifies that all other disclosures and exhibits from the original report and Amendment No. 1 remain unchanged by this new filing.

Does Wellgistics Health’s Amendment No. 2 change any prior 8-K disclosures?

The company states Amendment No. 2 does not modify or update any disclosures or exhibits from the original report or Amendment No. 1. It is limited to correcting and refiling Exhibit 4.3, keeping all other previously reported information the same.

What exhibit is being refiled in Wellgistics Health’s latest amendment?

Exhibit 4.3, identified as the Form of Placement Agent Warrant, is being replaced and refiled. This exhibit update is the only substantive change described, with all other exhibits and disclosures from earlier versions left intact by the amendment.

Does Amendment No. 2 for WGRX reflect any new corporate events?

The company specifically notes that Amendment No. 2 does not reflect any events that may have occurred after the original report. Its function is administrative, focusing solely on the corrected filing of the Placement Agent Warrant exhibit.

What exhibits are listed in Wellgistics Health’s 8-K/A Amendment No. 2?

The exhibits listed include 4.3, the Form of Placement Agent Warrant, and 104, the cover page interactive data file embedded within the Inline XBRL document. These are presented under the financial statements and exhibits section of the amendment.

Who signed Wellgistics Health’s Amendment No. 2 to the current report?

The amendment was signed on behalf of Wellgistics Health, Inc. by Prashant Patel, serving as Chief Executive Officer. His signature indicates the company’s authorization of the amended filing and the updated Placement Agent Warrant exhibit included with it.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A

Amendment No. 2

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 27, 2026

WELLGISTICS HEALTH, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-42530

93-3264234

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

3000 Bayport Drive

Suite 950

Tampa, FL

33607

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (844) 203-6092

Not Applicable

(Former name or former address, if changed since last report)

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.0001 par value per share		WGRX		The Nasdaq Capital Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 or Rule 12b-2 under the Securities Exchange Act of 1934.

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Explanatory Note

This Amendment No. 2 to the Current Report on Form 8-K (the “Amendment No. 2”) further amends the Current Report on Form 8-K filed by Wellgistics Health, Inc. (the “Company”) on May 29, 2026, as amended by Amendment No. 1 filed on June 2, 2026. The purpose of this Amendment No. 2 is to replace and refile Exhibit 4.3 included with Amendment No. 1. Other than as described above, this Amendment No. 2 does not modify or update any disclosures in or exhibits to the Original Report or Amendment No. 1, nor does it reflect any events that may have occurred subsequent to the Original Report.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
4.3		Form of Placement Agent Warrant.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 3, 2026	WELLGISTICS HEALTH, INC.

	By:	/s/ Prashant Patel
	Name:	Prashant Patel
	Title:	Chief Executive Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents